Guided Therapeutics (GTHP) Preferred Dividend Payments (2013 - 2025)

Guided Therapeutics (GTHP) has 13 years of Preferred Dividend Payments data on file, last reported at $24000.0 in Q4 2025.

• For the quarter ending Q4 2025, Preferred Dividend Payments fell 50.0% year-over-year to $24000.0; the trailing twelve-month figure through Dec 2025 stood at $148000.0 (down 14.94% YoY), and the FY2025 full-year result was $150000.0, down 13.79% from the prior year.
• Preferred Dividend Payments eased to $24000.0 in Q4 2025, from $43000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $548000.0 in Q1 2022 to a low of -$55000.0 in Q1 2021.
• A 5-year average of $73700.0 and a median of $47500.0 in 2022 frame the typical range for Preferred Dividend Payments.
• Across the five-year window, Preferred Dividend Payments sank 558.33% in 2021 and surged 1096.36% in 2022, its largest moves.
• Tracing GTHP's Preferred Dividend Payments over 5 years: stood at $65000.0 in 2021, then dropped by 23.08% to $50000.0 in 2022, then fell by 2.0% to $49000.0 in 2023, then slipped by 2.04% to $48000.0 in 2024, then tumbled by 50.0% to $24000.0 in 2025.
• Business Quant data shows GTHP's Preferred Dividend Payments at $24000.0 in Q4 2025, $43000.0 in Q3 2025, and $45000.0 in Q2 2025.